Successful Conjugate Vaccine Production – Case Study

Your peptide conjugate vaccine requires specialized expertise and technologies in order to achieve its next target inflection point.

Through the use of commercially available bi-functional linkers, Abzena’s conjugation team has the expertise to link custom peptides and polysaccharides to carrier proteins to generate novel vaccine conjugates. Access our case study to learn more about our approach.